Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings. [electronic resource]
Producer: 20150220Description: 717-25 p. digitalISSN:- 1473-5571
- Adolescent
- Adult
- Aged
- Alkynes
- Anti-HIV Agents -- adverse effects
- Antiretroviral Therapy, Highly Active -- adverse effects
- Benzoxazines -- adverse effects
- CD4 Lymphocyte Count
- Cyclohexanes -- adverse effects
- Cyclopropanes
- Double-Blind Method
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- HIV Infections -- drug therapy
- HIV-1 -- isolation & purification
- Humans
- Male
- Maraviroc
- Middle Aged
- Treatment Outcome
- Triazoles -- adverse effects
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.